HN protein inhib 
Welcome,         Profile    Billing    Logout  
 1 Company  1 Product   1 Product   34 Diseases   21 Trials   1163 News 
34 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
nitazoxanide / Generic mfg.
3C-SPS, NCT06827756: Comparative Study of Secondary Prophylaxis for SBP

Completed
4
90
RoW
Norfloxacin 400 MG, Nitazoxanide 500 MG, Colistin
Tanta University
Spontaneous Bacterial Peritonitis, Cirrhoses, Liver, Ascites
12/21
02/22
ACTRN12614000381684: A randomised, placebo-controlled trial of oral nitazoxanide for the empiric treatment of acute gastroenteritis among Australian Indigenous children

Terminated
4
300
 
Telethon Kids Institute, National Health and Medical Research Council, CentreCorp Foundation
Acute Gastroenteritis
 
 
NILE, NCT05184491: Nitazoxanide and Lansoprazole Based Regimens for H. Pylori Management

Recruiting
4
500
RoW
Naïve patients - ACO therapy, Naïve patients - LNDL therapy, Naïve patients - MNDL therapy, Treatment-experienced patients- LNDL therapy, Treatment-experienced patients- MNDL therapy
National Liver Institute, Egypt, Future pharmaceutical industries
Helicobacter Pylori
02/22
03/22
PENTZ, NCT04788407: Efficacy and Safety of Nitazoxanide for Post Exposure Prophylaxis of COVID-19 in Household Contacts

Recruiting
4
456
RoW
Nitazoxanide, Nixoran, Placebo
Fundación Huésped, Ministerio de Salud de Ciudad Autónoma de Buenos Aires, Laboratorios Roemmers S.A.I.C.F.
Covid19, SARS-CoV-2 Infection, Households Contacts
04/22
04/22
NCT04359680: Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Pre- and Post Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses (VRI) in Healthcare Workers and Others at Increased Risk of SARS-CoV-2 Infection

Completed
3
1407
US
Nitazoxanide, NTZ (nitazoxanide), NT-300, Placebo, Vitamin Super B-Complex
Romark Laboratories L.C.
COVID-19, Viral Respiratory Illnesses
04/21
04/21
NCT04746937: Nitazoxanide in Prevention of Secondary Spontaneous Peritonitis

Not yet recruiting
3
60
NA
Nitazoxanide, NTZ, Norfloxacin
Tanta University
Spontaneous Bacterial Peritonitis
03/22
05/22
NCT04392427: New Antiviral Drugs for Treatment of COVID-19

Not yet recruiting
3
100
RoW
Treatment group: will receive a combination of Nitazoxanide, Ribavirin and Ivermectin for a duration of seven days :, Nanozoxide, ivermectin and ribavirin 200 mg or 400 mg
Mansoura University
COVID, Drug Effect
05/22
05/22
NCT02621359: A Two Week Nitazoxanidebased Quadruple Regimen

Recruiting
3
100
RoW
Nitazoxanide, Alenia, nitclean, parazoxanide, Levofloxacin, Tavanic, levoxin, venaxan., Doxycyclin, Vibramycin, Doxymycin, Omeprazole, Omepak, Pepzole, Gasec, Risek.
Tanta University
Dyspepsia
12/22
12/22
NCT04423861: Efficacy and Safety of Nitazoxanide 600 mg BID Versus Placebo for the Treatment of Hospitalized Patients With COVID-19

Recruiting
3
380
RoW
Nitazoxanide, Viranitta (Nitazoxanide), Placebo
Azidus Brasil, Farmoquimica S.A.
covid19
03/23
03/23
NCT05480878: Role of Nitazoxanide and Escitalopram in Patients With Rheumatoid Arthritis

Completed
3
90
RoW
Placebo, Nitazoxanide 500Mg Oral Tablet, Escitalopram 10mg
Tanta University
Rheumatoid Arthritis
03/23
04/23
P-CABs, NCT06101420: Potassium Copetitive Acid Blockers Efficacy in H.Pylori Eradication

Completed
3
232
RoW
Vonoprazan, Clarithromycin, Amoxycillin, Esomeprazole, Levofloxacin, Doxycicline, Nitazoxanide
Ain Shams University
Helicobacter Pylori Eradication
06/23
06/23
NCT06817096: Efficacy and Safety of Nitazoxanide 600 Mg in the Outpatient Treatment of COVID-19 and Influenza

Not yet recruiting
3
340
NA
Nitazoxanide 600Mg Oral Tablet / placebo oral tablet
Azidus Brasil, Farmoquimica S.A.
Covid 19, Influenza
12/26
06/27
NCT06049901: Nitazoxanide in Patients With Metastatic Colorectal Cancer

Recruiting
3
60
RoW
Nitazoxanide, Nanazoxid
Tanta University
Metastatic Colorectal Cancer
03/25
03/26
NCT05157269: Trial to Evaluate Nitazoxanide for Treatment of Mild COVID-19 in Subjects Not at High Risk of Severe Illness

Withdrawn
3
600
NA
Nitazoxanide, NTZ, NT-300, Placebo, Vitamin Super-B Complex
Romark Laboratories L.C.
COVID-19
03/25
03/25
NCT06600711: Nitazoxanide for Treatment of Cryptosporidium in Children

Not yet recruiting
3
480
NA
Nitazoxanide, Placebo
Johns Hopkins Bloomberg School of Public Health, National Institute of Allergy and Infectious Diseases (NIAID)
Cryptosporidiosis
12/28
05/30
NCT04489381: Trial to Evaluate Efficacy and Safety of Nitazoxanide in the Treatment of Colds Due to Enterovirus/Rhinovirus Infection

Terminated
3
214
US
Nitazoxanide, NTZ (nitazoxanide), NT-300, Placebo, Vitamin Super B-Complex
Romark Laboratories L.C.
Enterovirus, Rhinovirus
01/21
02/21
NCT05157243: Trial to Evaluate Nitazoxanide for Treatment of Mild or Moderate COVID-19 in Subjects at High Risk of Severe Illness

Withdrawn
3
2000
NA
Nitazoxanide, NTZ, NT-300, Vitamin Super-B Complex, Placebo, Standard of Care, SOC
Romark Laboratories L.C.
COVID-19
05/25
05/25
NCT04161053: Efficacy and Safety of Nitazoxanide in Preventing Recurrence of Hepatic Encephalopathy

Recruiting
3
60
RoW
Rifaximin, Gastrobiotic, Trencedia, Nitazoxanide, Nanazoxid
Tanta University
Hepatic Encephalopathy
11/28
12/28
NCT04415983: Study of Nitazoxanide (NTZ) for Helicobacter Pylori in Children

Recruiting
3
100
RoW
Nitazoxanide, nanazoxid, Clarithromycin, Klacid, Metronidazole, Flagyl, Proton pump inhibitor
Tanta University
Helicobacter Pylori Infection
10/30
12/30
NCT04382846: Novel Regimens in COVID-19 Treatment

Recruiting
3
160
RoW
Nitazoxanide, Parazoxanide, Nanazoxid
Tanta University
COVID, Corona Virus Infection
12/30
12/30
NICEGUT, NCT02165813: Oral Nitazoxanide in Acute Gastroenteritis in Australian Indigenous Children

Terminated
2/3
216
RoW
Nitazoxanide, Alinia, placebo
Telethon Kids Institute, The University of Western Australia, Menzies School of Health Research
Gastroenteritis
04/21
06/21
NCT04959786: MANS-NRIZ Trial for COVID-19 Treatment : Extension Study

Recruiting
2/3
100
RoW
Ivermectin,ribavirin ,nitazoxanide and zinc
Mansoura University
COVID-19 Pneumonia
11/22
12/22
COVERAGE-A, NCT04920838: Early Treatment of Vulnerable Individuals With Non-Severe SARS-CoV-2 Infection

Recruiting
2/3
600
RoW
Nitazoxanide and Ciclésonide, Telmisartan 20Mg Oral Tablet, Paracetamol, Fluoxétine and Budésonide
ANRS, Emerging Infectious Diseases, University of Bordeaux, Institut National de la Santé Et de la Recherche Médicale, France, PACCI Program, Alliance for International Medical Action, Centre Muraz, Barcelona Institute for Global Health
Covid19, Covid19 Drug Treatment, Severe Acute Respiratory Syndrome Coronavirus 2, SARS-CoV2 Infection
08/23
08/23
NCT05897034: Combination Therapy Between Doxycycline, Pentoxifylline, and Nitazoxanide in Sexually Active Men

Not yet recruiting
2/3
100
NA
Doxycyclin, Pentoxifylline, Nitazoxanide 500Mg Oral Tablet
Tanta University, Marwa Ahmed El-Samongy
Sexually Transmitted Diseases
06/24
06/28
NCT03905655: Study of Nitazoxanide Compared to Placebo in Subjects With HBeAG-Negative Chronic Hepatitis B

Completed
2
51
RoW
Placebo Oral Tablet, Nitazoxanide, NTZ, NT-300
Romark Laboratories L.C.
Chronic Hepatitis B
03/21
10/21
FANTAZE, NCT04918927: Favipiravir +/- Nitazoxanide: Early Antivirals Combination Therapy in COVID-19

Completed
2
120
RoW
Favipiravir, Nitazoxanide, Daxon, Nitazoxanide Placebo, Daxon Placebo
Coordinación de Investigación en Salud, Mexico, University College, London, Centro de Investigacion y Estudios Avanzados del Instituto Politecnico Nacional (CINVESTAV), Universidad Autonoma de Guadalajara, Siegfried Rhein S.A. de C.V., Strides Pharma Science Limited, Hakken Enterprise
Covid19
03/23
03/23
PLATCOV, NCT05041907: Finding Treatments for COVID-19: A Trial of Antiviral Pharmacodynamics in Early Symptomatic COVID-19

Recruiting
2
3800
RoW
Nirmatrelvir/ritonavir (e.g. PAXLOVID™), Nitazoxanide, Molnupiravir and nirmatrelvir/ritonavir (e.g. PAXLOVID™), Hydroxychloroquine, No treatment, Monoclonal antibodies, Fluoxetine, Molnupiravir, Sotrovimab, Ensitrelvir, Favipiravir, Ivermectin, Remdesivir, Atilotrelvir/ritonavir, Metformin, Nirmatrelvir/ritonavir, Nirmatrelvir
University of Oxford
COVID-19
01/27
01/27
NCT06010992: Nitazoxanide as Adjuvant Therapy in Type 2 Diabetes Mellitus

Recruiting
2
70
RoW
Nitazoxanide
Tanta University, Menoufia University
Diabetes Mellitus, Type 2
10/24
01/25
NCT05453916: Comparing the Efficacy of Nitazoxanide Versus Rifaximin in Adult Patients With Irritable Bowel Syndrome Without Constipation

Recruiting
1/2
84
RoW
Nitazoxanide 500Mg Oral Tablet, Rifaximin 550Mg Tab
Sadat City University
Irritable Bowel Syndrome With Diarrhea
07/24
12/24
NCT04746183: AGILE (Early Phase Platform Trial for COVID-19)

Hourglass Jan 2022 - Jun 2022 : Data from AGILE trial for COVID-19
Active, not recruiting
1/2
600
Europe, RoW
CST-2: EIDD-2801, MK-4482, Molnupiravir, CST-2: Placebo, Placebo, Nitazoxanide, VIR-7832, VIR-7831, Sotrovimab, CST-5: Placebo, Favipiravir, Lagevrio, Paxlovid, nirmatrelvir and ritonavir
University of Liverpool, University of Southampton, Liverpool School of Tropical Medicine, Liverpool University Hospitals NHS Foundation Trust, University of Cambridge
Covid19
07/25
07/25
NCT03441893: Role of Intestinal Protozoa and Helminths in the Course of Ulcerative Colitis

Active, not recruiting
1/2
300
NA
parasitological diagnostics (coproscopy), Nitazoxanide 500Mg Oral Tablet, Mesalazine 250Mg Tablet and nitazoxanide 500Mg Oral Tablet, Mesalazine 250Mg, Placebo tabletes
Research Institute of Epidemiology, Microbiology and Infectious Diseases, Uzbekistan
Ulcerative Colitis, Ulcerative Colitis Exacerbation, Protozoan Infections, Helminth Infection
07/25
12/25
NCT04103216: Treatment of Cryptosporidiosis

Completed
N/A
64
RoW
Nitazoxanide with Lactobacillus Reuteri DSM 17938, Nitazoxanide
International Centre for Diarrhoeal Disease Research, Bangladesh, University of Virginia
Cryptosporidiosis
12/22
08/23
NCT05680792: Pharmacokinetic Interaction Between Nitazoxanide and Atazanavir/Ritonavir in Healthy Volunteers

Completed
N/A
17
RoW
Nitazoxanide, Netazox, Atazanavir/ritonavir
Obafemi Awolowo University, University of Liverpool
Drug Interaction
01/23
01/23
NSS-PC, NCT05648422: Effect of the Nutritional Support System on Neuromotor Alterations in Patients With Cerebral Palsy

Recruiting
N/A
144
RoW
Probiotics, Probiotics (Saccharomyces Boulardii), NSS Nutritional Support System, NSS, Deworming, Nitazoxanide, Specific diet, Conventional diet (WHO)
Anahuac University
Cerebral Palsy, Spastic, Malnutrition
01/25
01/25
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
nitazoxanide / Generic mfg.
3C-SPS, NCT06827756: Comparative Study of Secondary Prophylaxis for SBP

Completed
4
90
RoW
Norfloxacin 400 MG, Nitazoxanide 500 MG, Colistin
Tanta University
Spontaneous Bacterial Peritonitis, Cirrhoses, Liver, Ascites
12/21
02/22
ACTRN12614000381684: A randomised, placebo-controlled trial of oral nitazoxanide for the empiric treatment of acute gastroenteritis among Australian Indigenous children

Terminated
4
300
 
Telethon Kids Institute, National Health and Medical Research Council, CentreCorp Foundation
Acute Gastroenteritis
 
 
NILE, NCT05184491: Nitazoxanide and Lansoprazole Based Regimens for H. Pylori Management

Recruiting
4
500
RoW
Naïve patients - ACO therapy, Naïve patients - LNDL therapy, Naïve patients - MNDL therapy, Treatment-experienced patients- LNDL therapy, Treatment-experienced patients- MNDL therapy
National Liver Institute, Egypt, Future pharmaceutical industries
Helicobacter Pylori
02/22
03/22
PENTZ, NCT04788407: Efficacy and Safety of Nitazoxanide for Post Exposure Prophylaxis of COVID-19 in Household Contacts

Recruiting
4
456
RoW
Nitazoxanide, Nixoran, Placebo
Fundación Huésped, Ministerio de Salud de Ciudad Autónoma de Buenos Aires, Laboratorios Roemmers S.A.I.C.F.
Covid19, SARS-CoV-2 Infection, Households Contacts
04/22
04/22
NCT04359680: Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Pre- and Post Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses (VRI) in Healthcare Workers and Others at Increased Risk of SARS-CoV-2 Infection

Completed
3
1407
US
Nitazoxanide, NTZ (nitazoxanide), NT-300, Placebo, Vitamin Super B-Complex
Romark Laboratories L.C.
COVID-19, Viral Respiratory Illnesses
04/21
04/21
NCT04746937: Nitazoxanide in Prevention of Secondary Spontaneous Peritonitis

Not yet recruiting
3
60
NA
Nitazoxanide, NTZ, Norfloxacin
Tanta University
Spontaneous Bacterial Peritonitis
03/22
05/22
NCT04392427: New Antiviral Drugs for Treatment of COVID-19

Not yet recruiting
3
100
RoW
Treatment group: will receive a combination of Nitazoxanide, Ribavirin and Ivermectin for a duration of seven days :, Nanozoxide, ivermectin and ribavirin 200 mg or 400 mg
Mansoura University
COVID, Drug Effect
05/22
05/22
NCT02621359: A Two Week Nitazoxanidebased Quadruple Regimen

Recruiting
3
100
RoW
Nitazoxanide, Alenia, nitclean, parazoxanide, Levofloxacin, Tavanic, levoxin, venaxan., Doxycyclin, Vibramycin, Doxymycin, Omeprazole, Omepak, Pepzole, Gasec, Risek.
Tanta University
Dyspepsia
12/22
12/22
NCT04423861: Efficacy and Safety of Nitazoxanide 600 mg BID Versus Placebo for the Treatment of Hospitalized Patients With COVID-19

Recruiting
3
380
RoW
Nitazoxanide, Viranitta (Nitazoxanide), Placebo
Azidus Brasil, Farmoquimica S.A.
covid19
03/23
03/23
NCT05480878: Role of Nitazoxanide and Escitalopram in Patients With Rheumatoid Arthritis

Completed
3
90
RoW
Placebo, Nitazoxanide 500Mg Oral Tablet, Escitalopram 10mg
Tanta University
Rheumatoid Arthritis
03/23
04/23
P-CABs, NCT06101420: Potassium Copetitive Acid Blockers Efficacy in H.Pylori Eradication

Completed
3
232
RoW
Vonoprazan, Clarithromycin, Amoxycillin, Esomeprazole, Levofloxacin, Doxycicline, Nitazoxanide
Ain Shams University
Helicobacter Pylori Eradication
06/23
06/23
NCT06817096: Efficacy and Safety of Nitazoxanide 600 Mg in the Outpatient Treatment of COVID-19 and Influenza

Not yet recruiting
3
340
NA
Nitazoxanide 600Mg Oral Tablet / placebo oral tablet
Azidus Brasil, Farmoquimica S.A.
Covid 19, Influenza
12/26
06/27
NCT06049901: Nitazoxanide in Patients With Metastatic Colorectal Cancer

Recruiting
3
60
RoW
Nitazoxanide, Nanazoxid
Tanta University
Metastatic Colorectal Cancer
03/25
03/26
NCT05157269: Trial to Evaluate Nitazoxanide for Treatment of Mild COVID-19 in Subjects Not at High Risk of Severe Illness

Withdrawn
3
600
NA
Nitazoxanide, NTZ, NT-300, Placebo, Vitamin Super-B Complex
Romark Laboratories L.C.
COVID-19
03/25
03/25
NCT06600711: Nitazoxanide for Treatment of Cryptosporidium in Children

Not yet recruiting
3
480
NA
Nitazoxanide, Placebo
Johns Hopkins Bloomberg School of Public Health, National Institute of Allergy and Infectious Diseases (NIAID)
Cryptosporidiosis
12/28
05/30
NCT04489381: Trial to Evaluate Efficacy and Safety of Nitazoxanide in the Treatment of Colds Due to Enterovirus/Rhinovirus Infection

Terminated
3
214
US
Nitazoxanide, NTZ (nitazoxanide), NT-300, Placebo, Vitamin Super B-Complex
Romark Laboratories L.C.
Enterovirus, Rhinovirus
01/21
02/21
NCT05157243: Trial to Evaluate Nitazoxanide for Treatment of Mild or Moderate COVID-19 in Subjects at High Risk of Severe Illness

Withdrawn
3
2000
NA
Nitazoxanide, NTZ, NT-300, Vitamin Super-B Complex, Placebo, Standard of Care, SOC
Romark Laboratories L.C.
COVID-19
05/25
05/25
NCT04161053: Efficacy and Safety of Nitazoxanide in Preventing Recurrence of Hepatic Encephalopathy

Recruiting
3
60
RoW
Rifaximin, Gastrobiotic, Trencedia, Nitazoxanide, Nanazoxid
Tanta University
Hepatic Encephalopathy
11/28
12/28
NCT04415983: Study of Nitazoxanide (NTZ) for Helicobacter Pylori in Children

Recruiting
3
100
RoW
Nitazoxanide, nanazoxid, Clarithromycin, Klacid, Metronidazole, Flagyl, Proton pump inhibitor
Tanta University
Helicobacter Pylori Infection
10/30
12/30
NCT04382846: Novel Regimens in COVID-19 Treatment

Recruiting
3
160
RoW
Nitazoxanide, Parazoxanide, Nanazoxid
Tanta University
COVID, Corona Virus Infection
12/30
12/30
NICEGUT, NCT02165813: Oral Nitazoxanide in Acute Gastroenteritis in Australian Indigenous Children

Terminated
2/3
216
RoW
Nitazoxanide, Alinia, placebo
Telethon Kids Institute, The University of Western Australia, Menzies School of Health Research
Gastroenteritis
04/21
06/21
NCT04959786: MANS-NRIZ Trial for COVID-19 Treatment : Extension Study

Recruiting
2/3
100
RoW
Ivermectin,ribavirin ,nitazoxanide and zinc
Mansoura University
COVID-19 Pneumonia
11/22
12/22
COVERAGE-A, NCT04920838: Early Treatment of Vulnerable Individuals With Non-Severe SARS-CoV-2 Infection

Recruiting
2/3
600
RoW
Nitazoxanide and Ciclésonide, Telmisartan 20Mg Oral Tablet, Paracetamol, Fluoxétine and Budésonide
ANRS, Emerging Infectious Diseases, University of Bordeaux, Institut National de la Santé Et de la Recherche Médicale, France, PACCI Program, Alliance for International Medical Action, Centre Muraz, Barcelona Institute for Global Health
Covid19, Covid19 Drug Treatment, Severe Acute Respiratory Syndrome Coronavirus 2, SARS-CoV2 Infection
08/23
08/23
NCT05897034: Combination Therapy Between Doxycycline, Pentoxifylline, and Nitazoxanide in Sexually Active Men

Not yet recruiting
2/3
100
NA
Doxycyclin, Pentoxifylline, Nitazoxanide 500Mg Oral Tablet
Tanta University, Marwa Ahmed El-Samongy
Sexually Transmitted Diseases
06/24
06/28
NCT03905655: Study of Nitazoxanide Compared to Placebo in Subjects With HBeAG-Negative Chronic Hepatitis B

Completed
2
51
RoW
Placebo Oral Tablet, Nitazoxanide, NTZ, NT-300
Romark Laboratories L.C.
Chronic Hepatitis B
03/21
10/21
FANTAZE, NCT04918927: Favipiravir +/- Nitazoxanide: Early Antivirals Combination Therapy in COVID-19

Completed
2
120
RoW
Favipiravir, Nitazoxanide, Daxon, Nitazoxanide Placebo, Daxon Placebo
Coordinación de Investigación en Salud, Mexico, University College, London, Centro de Investigacion y Estudios Avanzados del Instituto Politecnico Nacional (CINVESTAV), Universidad Autonoma de Guadalajara, Siegfried Rhein S.A. de C.V., Strides Pharma Science Limited, Hakken Enterprise
Covid19
03/23
03/23
PLATCOV, NCT05041907: Finding Treatments for COVID-19: A Trial of Antiviral Pharmacodynamics in Early Symptomatic COVID-19

Recruiting
2
3800
RoW
Nirmatrelvir/ritonavir (e.g. PAXLOVID™), Nitazoxanide, Molnupiravir and nirmatrelvir/ritonavir (e.g. PAXLOVID™), Hydroxychloroquine, No treatment, Monoclonal antibodies, Fluoxetine, Molnupiravir, Sotrovimab, Ensitrelvir, Favipiravir, Ivermectin, Remdesivir, Atilotrelvir/ritonavir, Metformin, Nirmatrelvir/ritonavir, Nirmatrelvir
University of Oxford
COVID-19
01/27
01/27
NCT06010992: Nitazoxanide as Adjuvant Therapy in Type 2 Diabetes Mellitus

Recruiting
2
70
RoW
Nitazoxanide
Tanta University, Menoufia University
Diabetes Mellitus, Type 2
10/24
01/25
NCT05453916: Comparing the Efficacy of Nitazoxanide Versus Rifaximin in Adult Patients With Irritable Bowel Syndrome Without Constipation

Recruiting
1/2
84
RoW
Nitazoxanide 500Mg Oral Tablet, Rifaximin 550Mg Tab
Sadat City University
Irritable Bowel Syndrome With Diarrhea
07/24
12/24
NCT04746183: AGILE (Early Phase Platform Trial for COVID-19)

Hourglass Jan 2022 - Jun 2022 : Data from AGILE trial for COVID-19
Active, not recruiting
1/2
600
Europe, RoW
CST-2: EIDD-2801, MK-4482, Molnupiravir, CST-2: Placebo, Placebo, Nitazoxanide, VIR-7832, VIR-7831, Sotrovimab, CST-5: Placebo, Favipiravir, Lagevrio, Paxlovid, nirmatrelvir and ritonavir
University of Liverpool, University of Southampton, Liverpool School of Tropical Medicine, Liverpool University Hospitals NHS Foundation Trust, University of Cambridge
Covid19
07/25
07/25
NCT03441893: Role of Intestinal Protozoa and Helminths in the Course of Ulcerative Colitis

Active, not recruiting
1/2
300
NA
parasitological diagnostics (coproscopy), Nitazoxanide 500Mg Oral Tablet, Mesalazine 250Mg Tablet and nitazoxanide 500Mg Oral Tablet, Mesalazine 250Mg, Placebo tabletes
Research Institute of Epidemiology, Microbiology and Infectious Diseases, Uzbekistan
Ulcerative Colitis, Ulcerative Colitis Exacerbation, Protozoan Infections, Helminth Infection
07/25
12/25
NCT04103216: Treatment of Cryptosporidiosis

Completed
N/A
64
RoW
Nitazoxanide with Lactobacillus Reuteri DSM 17938, Nitazoxanide
International Centre for Diarrhoeal Disease Research, Bangladesh, University of Virginia
Cryptosporidiosis
12/22
08/23
NCT05680792: Pharmacokinetic Interaction Between Nitazoxanide and Atazanavir/Ritonavir in Healthy Volunteers

Completed
N/A
17
RoW
Nitazoxanide, Netazox, Atazanavir/ritonavir
Obafemi Awolowo University, University of Liverpool
Drug Interaction
01/23
01/23
NSS-PC, NCT05648422: Effect of the Nutritional Support System on Neuromotor Alterations in Patients With Cerebral Palsy

Recruiting
N/A
144
RoW
Probiotics, Probiotics (Saccharomyces Boulardii), NSS Nutritional Support System, NSS, Deworming, Nitazoxanide, Specific diet, Conventional diet (WHO)
Anahuac University
Cerebral Palsy, Spastic, Malnutrition
01/25
01/25

Download Options